Author

Lissa L. Collin

Observed name: Lissa Collin

Institution: GlaxoSmithKline (United Kingdom)

Observed institution: GlaxoSmithKline (United Kingdom)

OpenAlex ID: A5110076367

A Novel, Potent, and Selective 5-HT7Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)

2000 · Peter J. Lovell, Steven M. Bromidge, et al. · Journal of Medicinal Chemistry · 257

Functional characterisation of the human cloned 5‐HT7 receptor (long form); antagonist profile of SB‐258719

1998 · David R. Thomas, Susan A. Gittins, et al. · British Journal of Pharmacology · 123

(R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT7Receptor Antagonist

1998 · Ian T. Forbes, Steven Dabbs, et al. · Journal of Medicinal Chemistry · 110

Works count: 3

Citation count: 490

H-index: 3

I10-index: 3